Mark M. Webber
2008
In 2008, Mark M. Webber earned a total compensation of $481.8K as Former Chief Financial Officer at Sarepta Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $259,536 |
|---|---|
| Salary | $222,310 |
| Total | $481,846 |
Webber received $259.5K in option awards, accounting for 54% of the total pay in 2008.
Webber also received $222.3K in salary.
Rankings
In 2008, Mark M. Webber's compensation ranked 6,629th out of 9,135 executives tracked by ExecPay. In other words, Webber earned more than 27.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,629 out of 9,135 | 27th |
Division Manufacturing | 2,463 out of 3,436 | 28th |
Major group Chemicals And Allied Products | 551 out of 815 | 32nd |
Industry group Drugs | 381 out of 597 | 36th |
Industry Pharmaceutical Preparations | 281 out of 408 | 31st |
Source: SEC filing on April 14, 2009.
Webber's colleagues
We found seven more compensation records of executives who worked with Mark M. Webber at Sarepta Therapeutics in 2008.
2008
Leslie Hudson
Sarepta Therapeutics
Chief Executive Officer
2008
Alan Timmins
Sarepta Therapeutics
Chief Operating Officer
2008
J Boyle
Sarepta Therapeutics
Chief Financial Officer
2008
Dwight Weller
Sarepta Therapeutics
Senior Vice President of Chemistry and Manufacturing
2008
Peter O'Hanley
Sarepta Therapeutics
SVP of Clinical Development and Regulatory Affairs
2008
Patrick Iversen
Sarepta Therapeutics
Senior Vice President of Strategic Alliances
2008
K Forrest
Sarepta Therapeutics